Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,123 | -2,380 | -4,563 | -2,667 | -4,528 |
| Depreciation Amortization | 12 | 686 | 357 | 323 | 77 |
| Other Working Capital | 991 | 1,107 | 3,202 | 308 | 2,171 |
| Other Operating Activity | 594 | 206 | 229 | 232 | 583 |
| Operating Cash Flow | $-527 | $-381 | $-775 | $-1,804 | $-1,697 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -23 | -28 | -44 | -32 | -37 |
| Other Investing Activity | -23 | -28 | -44 | -32 | -37 |
| Investing Cash Flow | $-23 | $-28 | $-44 | $-32 | $-37 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 323 | 264 | N/A | 1,381 | 1,165 |
| Debt Issued | N/A | 62 | N/A | N/A | N/A |
| Common Stock Issued | 439 | 63 | 550 | 678 | 600 |
| Other Financing Activity | 292 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,054 | $389 | $550 | $2,059 | $1,765 |
| Beginning Cash Position | 5 | 26 | 295 | 72 | 42 |
| End Cash Position | 510 | 5 | 26 | 295 | 72 |
| Net Cash Flow | $505 | $-21 | $-269 | $223 | $31 |
| Free Cash Flow | |||||
| Operating Cash Flow | -527 | -381 | -775 | -1,804 | -1,697 |
| Free Cash Flow | -527 | -381 | -775 | -1,804 | -1,697 |